Understanding the genetics of peripartum depression: Research challenges, strategies, and opportunities.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
genome-wide association studies
major depressive disorder
polygenic risk scores
women’s mental health
Journal titleFrontiers in genetics
Publication Begin page1022188
MetadataShow full item record
AbstractPeripartum depression (PD) is a common mood disorder associated with negative outcomes for mother and child. PD is an understudied disorder in psychiatric genetics, and progress characterizing its genetic architecture has been limited by a lack of disorder-specific research, heterogeneous and evolving phenotypic definitions, inadequate representation of global populations, low-powered studies, and insufficient data amenable to large meta-analyses. The increasing availability of large-scale, population-level efforts, like biobanks, have the potential to accelerate scientific discovery and translational research by leveraging clinical, molecular, and self-report data from hundreds of thousands of individuals. Although these efforts will not fully equip researchers to confront every challenge posed by systemic issues in data collection, such as the reliance on minimal phenotyping strategies, the field is in a position to learn from other successful psychiatric genetic investigations. This review summarizes the current state of PD genetics research and highlights research challenges, including the impact of phenotype depth, measurement, and definition on the replicability and interpretability of genomic research. Recommendations for advancing health equity and improving the collection, analysis, discussion, and reporting of measures for PD research are provided.
CitationLancaster EE, Lapato DM, Peterson RE. Understanding the genetics of peripartum depression: Research challenges, strategies, and opportunities. Front Genet. 2022 Nov 17;13:1022188. doi: 10.3389/fgene.2022.1022188. PMID: 36468033; PMCID: PMC9714263.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Copyright © 2022 Lancaster, Lapato and Peterson.
- Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
- Authors: Cerbo AD
- Issue date: 2021
- Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression.
- Authors: Mitchell BL, Thorp JG, Wu Y, Campos AI, Nyholt DR, Gordon SD, Whiteman DC, Olsen CM, Hickie IB, Martin NG, Medland SE, Wray NR, Byrne EM
- Issue date: 2021 Oct 1
- The future of Cochrane Neonatal.
- Authors: Soll RF, Ovelman C, McGuire W
- Issue date: 2020 Nov
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
- Authors: Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P
- Issue date: 2022 Feb 1
- Qualitative Study.
- Authors: Tenny S, Brannan JM, Brannan GD
- Issue date: 2023 Jan
Showing items related by title, author, creator and subject.
Preoperative Depression Screening in Primary Lumbar Fusion: An Evaluation of Its Modifiability on Outcomes in Patients with Diagnosed Depressive Disorder.Gordon, Adam M; Elali, Faisal R; Ton, Andy; Schwartz, Jake M; Miller, Chaim; Alluri, Ram K (2023-05-11)Studies have reported the detrimental effects of depression following spine surgery, however none have evaluated whether preoperative depression screening, in patients with a history of depression, is protective from adverse outcomes and lowers healthcare costs. We studied whether depression screenings/psychotherapy visits within 3 months prior to 1-2 level lumbar fusion (1-2LF) were associated with lower: 1) medical complications; 2) emergency department (ED) utilizations; 3) readmissions; and 4) healthcare costs.
Using the Center for Epidemiologic Studies Depression Scale to assess depression in women with HIV and women at risk for HIV: Are somatic items invariant?Adams, Leah M; Wilson, Tracey E; Merenstein, Daniel; Milam, Joel; Cohen, Jennifer; Golub, Elizabeth T; Adedimeji, Adebola; Cook, Judith A (2017-02-23)The prevalence of depression among women living with HIV/AIDS is elevated, compared with women in the general population and men diagnosed with HIV/AIDS. Although symptoms of HIV may overlap with somatic symptoms of depression, little research has explored how well screening tools accurately assess depression rather than symptoms of HIV/AIDS among women. The present study examined the utility of a widely used tool for assessing depression symptoms among women living with HIV/AIDS. Data are from the Women's Interagency HIV Study (WIHS), a multisite, longitudinal cohort study of women living with HIV/AIDS (n = 1,329) and seronegative women (n = 541) matched on key risk factors for HIV/AIDS. Confirmatory factor analysis-based measurement invariance tests of the Center for Epidemiologic Studies Depression Scale (CES-D) were conducted to determine whether women with HIV and those without HIV responded to the scale similarly. Results supported measurement invariance of CES-D scores. Findings suggest that the CES-D can be used to assess for burden of depression symptoms among women diagnosed with HIV/AIDS. (PsycINFO Database Record
"What if I had never been depressed?": effect of counterfactual thinking on stigma for individuals who have experienced depressionTozser, Timea (2018-05)Depression is identified as one of the most common mental illnesses in the United States (NIMH, 2014). To understand such prevalence, many researchers have focused on the cognitive patterns associated with depression, suggesting that depressed individuals focus their attention on experiences of disappointment, worthlessness, and rejection (Gotlib & Joormann, 2010). This may include counterfactual thinking patterns that center upon detrimental “what ifs” that impede meaning-making, a process known to benefit individuals and reduce stigma. Accordingly, the purpose of the current study was to explore the relationship between depression, counterfactual thinking, and stigma. Using a mixed methods design, participants were randomly assigned to consider ways in which their life might have been better or worse if they had never had depression. They also completed a series of questionnaires and open-ended questions. The results indicated that individuals who were randomly assigned and prompted to think either about negative and positive counterfactuals perceived higher levels of stigma than those in the control group. Additionally, individuals who wrote about ways their life would be better without depression reported greater meaning making than those who wrote about ways their life could have been worse. Lastly, systematic differences in emergent themes of meaning-making were identified between groups. The current research sheds light on depression narratives and how individuals create meaning about depression.